Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene
- PMID: 17661818
- DOI: 10.1111/j.1399-0004.2007.00829.x
Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene
Abstract
Fragile X (FRAX) syndrome is a commonly inherited form of mental retardation resulting from the lack of expression of the fragile X mental retardation protein (FMRP). It is caused by a stretch of CGG repeats within the fragile X gene, which can be unstable in length as it is transmitted from generation to generation. Once the repeat exceeds a threshold length, the FMR1 gene is methylated and no protein is produced resulting in the fragile X phenotype. The consequences of FMRP absence in the mechanisms underlying mental retardation are unknown. We have identified a male patient in a classical FRAX family without the characteristic FRAX phenotype. His intelligence quotient (IQ) is borderline normal despite the presence of a mosaic pattern of a pre-mutation (25%), full mutation (60%) and a deletion (15%) in the FMR1 gene. The cognitive performance was determined at the age of 28 by the Raven test and his IQ was 81. However, FMRP expression studies in both hair roots and lymphocytes, determined at the same time as the IQ test, were within the affected male range. The percentage of conditioned responses after delay eyeblink conditioning was much higher than the average percentage measured in FRAX studies. Moreover, this patient showed no correlation between FMRP expression and phenotype and no correlation between DNA diagnostics and phenotype.
Similar articles
-
The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.Brain. 2004 Dec;127(Pt 12):2672-81. doi: 10.1093/brain/awh256. Epub 2004 Oct 13. Brain. 2004. PMID: 15483045
-
Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.Am J Med Genet. 1999 Apr 2;83(4):286-95. Am J Med Genet. 1999. PMID: 10208163
-
The emerging fragile X premutation phenotype: evidence from the domain of social cognition.Brain Cogn. 2005 Feb;57(1):53-60. doi: 10.1016/j.bandc.2004.08.020. Brain Cogn. 2005. PMID: 15629215 Clinical Trial.
-
Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.Microsc Res Tech. 2002 May 1;57(3):135-44. doi: 10.1002/jemt.10066. Microsc Res Tech. 2002. PMID: 12112448 Review.
-
Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.Growth Horm IGF Res. 2004 Jun;14 Suppl A:S158-65. doi: 10.1016/j.ghir.2004.03.034. Growth Horm IGF Res. 2004. PMID: 15135801 Review.
Cited by
-
Clinical and molecular implications of mosaicism in FMR1 full mutations.Front Genet. 2014 Sep 17;5:318. doi: 10.3389/fgene.2014.00318. eCollection 2014. Front Genet. 2014. PMID: 25278957 Free PMC article.
-
The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model.Hum Mutat. 2014 Jan;35(1):129-36. doi: 10.1002/humu.22464. Hum Mutat. 2014. PMID: 24130133 Free PMC article.
-
The multiple molecular facets of fragile X-associated tremor/ataxia syndrome.J Neurodev Disord. 2014;6(1):23. doi: 10.1186/1866-1955-6-23. Epub 2014 Jul 30. J Neurodev Disord. 2014. PMID: 25161746 Free PMC article. Review.
-
Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.Hum Mol Genet. 2015 Dec 15;24(24):7087-96. doi: 10.1093/hmg/ddv408. Epub 2015 Sep 29. Hum Mol Genet. 2015. PMID: 26420841 Free PMC article.
-
Finding FMR1 mosaicism in Fragile X syndrome.Expert Rev Mol Diagn. 2016;16(4):501-7. doi: 10.1586/14737159.2016.1135739. Epub 2016 Feb 9. Expert Rev Mol Diagn. 2016. PMID: 26716517 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical